Evaluation of Human Absorbed Dose of 177Lu-DOTA-Trastuzumab Based on its Biodistribution Studies in Rats

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

YOUSEFNIA H.; ABBASI DAVANI F.; AFARIDEH H.; JALILIAN A.R.; SHIRVANI ARANI S.; BAHRAMI SAMANI A.; GHANNADI MARAGHEH M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY Year:2016 | Volume:- | Issue:76 Page(s): 8-15

Download Full-Text

Persian Verion

View:

541

Download:

Cites:

Information Journal Paper

Title

Evaluation of Human Absorbed Dose of 177Lu-DOTA-Trastuzumab Based on its Biodistribution Studies in Rats

Author(s)

Keywords

TrastuzumabQ1

177LuQ1

BiodistributionQ2

Absorbed doseQ1

Abstract

In this study, Trastuzumab was labeled with 177Lu, and its dosimetric calculation was performed considering the assessment of the Absorbed dose in the organs of human body. 177Lu chloride was prepared after 7 days irradiation of enriched Lu2O3 in the Tehran Research Reactor at the thermal neutron flux of 4×1013 cm-2 s-1, and the specific activity of 70-80 GBq/mg. 177Lu-DOTA-Trastuzumab was obtained with an overall radiochemical purity of >98% under the optimized conditions. Biodistribution studies of the radioimmunoconjugate in normal rats were carried up to 168 h. Relative organ mass extrapolation method was used for calculation of the human Absorbed dose. Because of the highest accumulation activity in reticuloendothelial system, liver and spleen have received the maximum dose of 0. 95 and 0. 89 mSv/MBq, respectively.

Cites

No record.

References

No record.

Cite

APA: Copy

YOUSEFNIA, H., ABBASI DAVANI, F., AFARIDEH, H., JALILIAN, A.R., SHIRVANI ARANI, S., BAHRAMI SAMANI, A., & GHANNADI MARAGHEH, M.. (2016). Evaluation of Human Absorbed Dose of 177Lu-DOTA-Trastuzumab Based on its Biodistribution Studies in Rats. JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY, -(76 ), 8-15. SID. https://sid.ir/paper/97702/en

Vancouver: Copy

YOUSEFNIA H., ABBASI DAVANI F., AFARIDEH H., JALILIAN A.R., SHIRVANI ARANI S., BAHRAMI SAMANI A., GHANNADI MARAGHEH M.. Evaluation of Human Absorbed Dose of 177Lu-DOTA-Trastuzumab Based on its Biodistribution Studies in Rats. JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY[Internet]. 2016;-(76 ):8-15. Available from: https://sid.ir/paper/97702/en

IEEE: Copy

H. YOUSEFNIA, F. ABBASI DAVANI, H. AFARIDEH, A.R. JALILIAN, S. SHIRVANI ARANI, A. BAHRAMI SAMANI, and M. GHANNADI MARAGHEH, “Evaluation of Human Absorbed Dose of 177Lu-DOTA-Trastuzumab Based on its Biodistribution Studies in Rats,” JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY, vol. -, no. 76 , pp. 8–15, 2016, [Online]. Available: https://sid.ir/paper/97702/en

Related Journal Papers